rethinkPeptides Search
Menu
Study breakdown

Self-Assembling AMP Prodrugs: A Revolution in Antimicrobial Peptide Drug Delivery

evidence
The takeaway

Self-assembling prodrugs composed of antimicrobial peptides spontaneously form nanostructures that improve stability, targeting, and controlled release — revolutionizing AMP delivery.

Drug IS the delivery system

AMP prodrugs self-assemble into their own nanoparticle carriers — eliminating carrier materials while improving stability and targeting

What the researchers found

Self-assembling AMP prodrugs: spontaneous nanostructure formation providing stability, targeting, and controlled release without carrier materials — carrier-free AMP delivery revolution.

Why it matters

AMP delivery is the biggest barrier to clinical use. Self-assembling prodrugs eliminate the carrier — the AMP IS the delivery system.

How the study worked

Review of self-assembling AMP prodrug design, nanostructure formation, and therapeutic applications.

What this study cannot tell us

Emerging field. Many designs still preclinical.

How to read the evidence

Review of emerging self-assembling AMP prodrug field.

When this study was published

Published in 2025.

The bigger picture

Self-assembling prodrugs represent the ultimate simplification of drug delivery — the drug molecule itself becomes the delivery vehicle.

Questions still open

  • Which AMP sequences best self-assemble into therapeutic nanostructures?
  • Can assembly be triggered by infection-site stimuli?
  • Would self-assembling AMPs maintain activity after disassembly?

Common questions

What is a self-assembling AMP prodrug?
An antimicrobial peptide designed to spontaneously form its own nanoparticle structure. The drug molecule IS the delivery vehicle — no carrier materials needed.
Why is this revolutionary?
It eliminates the biggest AMP delivery barrier. Instead of wrapping AMPs in complex carrier systems, the peptides are designed to deliver themselves.

Read the original research

Self-assemblies from prodrugs composed of antimicrobial peptides: a revolution in local lung cancer treatment, with microbiota as a main actor.

Drug delivery and translational research

Citation

Ladaycia, Abdallah; Lemaire, Laurent; Pailhoriès, Hélène; Lautram, Nolwenn; Franconi, Florence; Pigeon, Pascal; Jaouen, Gérard; Passirani, Catherine; Lepeltier, Elise. (2026). Self-assemblies from prodrugs composed of antimicrobial peptides: a revolution in local lung cancer treatment, with microbiota as a main actor.. Drug delivery and translational research. https://doi.org/10.1007/s13346-025-02037-x